Principles and Practice of Pharmaceutical Medicine. (Record no. 29799)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03225nam a22003257a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241111115741.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241111120329.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241111b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-0-470-09313-9 (cloth: alk. paper) |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.19 EDW |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Lionel D. Edwards |
| 222 ## - KEY TITLE | |
| Key title | Principles and Practice of Pharmaceutical Medicine. |
| Qualifying information | ¼ activities administration adverse drug reactions adverse events advertising analysis application approval assessment audit biological CHMP Clin clinical research clinical studies clinical trials compliance conduct costs countries CRFs CRO data mining database disease documents dose drug development DTC advertising effect efficacy EMEA ethics committee European evaluation example FDA GCP groups Guidance guidelines Health healthcare human important increased informed consent interactions investigational product investigator involved issues labeling manufacturing measures medicinal products ment metabolism mithridatium monitoring NDA orphan drug OTC outcomes patients pediatric phar pharma pharmaceutical companies pharmaceutical industry Pharmaceutical Medicine pharmaceutical physician pharmacoeconomic pharmacokinetic pharmacology pharmacovigilance phase placebo plasma population potential prescribed prescription procedures protocol regulations regulatory authorities reports response risk safety sample scientific specific sponsor standards statistical subjects thalidomide therapeutic therapy tion toxicity treatment United Kingdom usually |
| 240 ## - UNIFORM TITLE | |
| Uniform title | Principles and Practice of Pharmaceutical Medicine. |
| 245 ## - TITLE STATEMENT | |
| Title | Principles and Practice of Pharmaceutical Medicine. |
| 246 ## - VARYING FORM OF TITLE | |
| Title proper/short title | Principles and Practice of Pharmaceutical Medicine. |
| 247 ## - FORMER TITLE | |
| Title | Principles and Practice of Pharmaceutical Medicine. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd. Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | 111 River Street, Hoboken, NJ 07030, USA | |
| Name of publisher, distributor, etc. | John Wiley & Sons Inc | |
| Date of publication, distribution, etc. | 2007. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 780 Pages |
| Extent | Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The long awaited second edition of Principles and Practice of Pharmaceutical Medicine provides an invaluable guide to all areas of drug development and medical aspects of marketing. The title has been extensively revised and expanded to include the latest regulatory and scientific developments. New chapters include: European Regulations Ethics of Pharmaceutical Medicine Licensing and Due Diligence Pharmacogenomics<br/>Encompassing the entire spectrum of pharmaceutical medicine, it is the most up-to-date international guide currently available.<br/><br/>Review of the first edition:<br/><br/>“This book was a joy to read and a joy to review. All pharmaceutical physicians should have a copy on their bookshelves, all pharmaceutical companies should have copies in their libraries.”<br/>—BRITISH ASSOCIATION OF PHARMACEUTICAL PHYSICIANS |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / General, Medical / Pharmacology, Business & Economics / Industries / Pharmaceutical & Biotechnology, Medical / Pharmacy, Drug development, Drugs -- Research, Pharmacology. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Fuller form of name | Peter D. Stonier |
| Fuller form of name | Andrew J. Fletcher |
| Fuller form of name | Anthony W. Fox |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/11/2024 | 615.19 EDW | 20241111115741.0 | 11/11/2024 | 20241111115741.0 | 11/11/2024 | E-BOOKS |